IgA nephropathy (IgAN) often progresses to end stage renal disease (ESRD) and patients with IgA nephropathy are frequently ideal candidates for kidney transplantation. Recurrent IgAN (r-IgAN) occurs in up to 60% of patients which may lead to allograft lost in kidney transplant recipients. The mechanism of recurrence is often multi-factorial; however, recent literature suggests risks including immunosuppression, transplant type, donor status [genetically living related vs unrelated] and recipient HLA characteristics. The objective of this single institution retrospective study is to evaluate r-IgAN and outcome of r-IgAN post kidney transplantation in patients who underwent kidney transplantation at our institution.